New research from the University of Alabama at Birmingham (UAB) says low potassium levels produce an increased risk of death or hospitalization in patients with heart failure and chronic kidney disease (CKD). In findings reported in January in Circulation: Heart Failure, a journal of the American Heart Association, the researchers say that even a mild decrease in serum potassium level increased the risk of death in this patient group. "Hypokalemia, or low potassium, is common in heart-failure patients and is associated with poor outcomes, as is chronic kidney disease, " said C. Barrett Bowling, M.D., a fellow in the UAB Division of Gerontology, Geriatrics and Palliative Care.
Designed for a wide spectrum of generalists and specialists who diagnose and manage cardiovascular conditions, the Providence Medical Centers' 16th Annual Cardiovascular Symposium will explore new advances in preventive and interventional cardiology, electrophysiology, and vascular and cardiovascular surgery. Held Friday and Saturday, February 26 and 27, at the Sheraton Universal Hotel in Universal City, California, a highlight of the Symposium will be a live feed carotid stent procedure performed by Zahi Nassoura, MD, FACS. Sessions will provide updates on preventive cardiology, interventional treatments, cardiac arrhythmia, lead extraction surgery, cardiac surgery and vascular disease.
Statement Of Health And Human Services Secretary Kathleen Sebelius On American Heart Month February 2010
American Heart Month is a time to spread awareness of the dangers of heart disease and stroke, and recommit to strengthening prevention, improving treatments, and helping all Americans live longer, healthier lives. Hundreds of thousands of American families are devastated each year by heart disease. Even though the risk factors for heart disease can be prevented or controlled, it is the leading killer of both men and women in the United States. And yet, heart disease is preventable. By leading a healthy lifestyle, Americans can lower their risk of heart disease by as much as 82 percent. This means following a heart healthy eating plan, getting regular physical activity, maintaining a healthy weight, and not smoking.
Early life stress could be a risk factor for cardiovascular disease in adulthood, researchers report. "We think early life stress increases sensitivity to a hormone known to increase your blood pressure and increases your cardiovascular risk in adult life, " said Dr. Jennifer Pollock, biochemist in the Vascular Biology Center at the Medical College of Georgia and corresponding author on the study published online in Hypertension. The studies in a proven model of chronic behavioral stress - separating rat pups from their mother three hours daily for two weeks - showed no long-term impact on key indicators of cardiovascular disease such as increased blood pressure, heart rate or inflammation in blood vessel walls.
Researchers at the Methodist DeBakey Heart & Vascular Center have shown that a simple, inexpensive test can determine whether it is safe to send home a patient who comes to the emergency room with chest pain. "It is imperative to accurately diagnose patients who come to the emergency department with chest pain, " said Dr. John Mahmarian, cardiologist at the Methodist DeBakey Heart & Vascular Center and principal investigator of the study. "Unfortunately, diagnosing chest pain is often expensive and time-consuming. This new data could save millions of health care dollars and countless hours spent waiting on unnecessary tests." Mahmarian's research, which was published online today in the Annals of Emergency Medicine, shows that patients with a coronary artery calcium score of zero can be safely sent home without further cardiac testing.
An innovative cardiac scanner will dramatically improve the process of diagnosing heart conditions. The portable magnetometer* is being developed at the University of Leeds, with funding from the Engineering and Physical Sciences Research Council (EPSRC) playing a key role. Due to its unprecedented sensitivity to magnetic fluctuations the device will be able to detect a number of conditions, including heart problems in foetuses, earlier than currently available diagnostic techniques such as ultrasound, ECG (electrocardiogram) and existing cardiac magnetometers. It will also be smaller, simpler to operate, able to gather more information and significantly cheaper than other devices currently available.
The risk for heart-related death is increasing in young adults ages 35 to 54, and the numbers are even more alarming for younger women. It is the number-one cause of death for both men and women in the United States, yet every year since 1984 more women have died of cardiovascular health problems than men, according to the American Heart Association. "Although there has been a general decline in deaths caused by heart disease, the last decade has seen a steady increase among younger women ages 35 to 44. Women account for more than 50 percent of deaths due to heart disease, " says Dr. Holly Andersen, the director of education and outreach for the Ronald O.
Sorin Group Announces Market Release And First Implant Of Next-Generation Cardiac Resynchronization Therapy Defibrillator
Sorin Group (MIL:SRN) (Reuters Code: SORN.MI), a global leader in the treatment of cardiovascular disease, announced U.S. FDA approval and first implant of its next-generation of cardiac resynchronization therapy defibrillator (CRT-D), Paradym™ CRT Model 8750. Featuring a new, state-of-the-art battery technology, Paradym™ CRT delivers 37 Joules, the highest energy of any implantable cardiac defibrillator (ICD) currently available. In addition, Paradym™ offers consistent charge times throughout the life of the device (10s at Beginning Of Life, 13s at Elective Replacement Indicator - ERI), improved longevity, and a 6-month ERI to End of Service (EOS) period, twice as long as any other ICD.
Bobby Dhawan, 51, is the owner of a successful taxi service in Germany. Normally, he does not allow bumper stickers to be placed on his cabs, but recently, he made a special exception for a sticker which reads, "Don't take your organs to heaven - heaven knows we need them here! " Last August, Dhawan received a donor heart transplant after living for 615 days with a SynCardia temporary CardioWest™ Total Artificial Heart. For nearly a year and a half prior to his transplant, Dhawan had enjoyed life at home with his family and gone back to work using the European portable driver to power his Total Artificial Heart. "With the Total Artificial Heart, my health was so good and I felt so strong.
Medtronic Announces Two Late Breaking Clinical Trials Accepted For American College Of Cardiology Meeting
Medtronic, Inc. (NYSE: MDT) announced pivotal data for the Medtronic Arctic Front® CryoAblation Catheter System will be presented as a late breaking clinical trial at the 59th Annual Scientific Session of the American College of Cardiology on Monday, March 15 at 8 a.m. ET. The STOP-AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial is evaluating the safety and efficacy of the Arctic Front CryoAblation Catheter System for paroxysmal atrial fibrillation (AF) patients. The system is approved for use in Europe, Australia and Hong Kong and is under investigational use in the United States. Additionally, data from the Medtronic-sponsored CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) clinical trial also will be presented as a late breaker on Monday, March 15.